Colossal Biosciences is reportedly in talks to raise new capital at a $20 billion to $30 billion valuation, aiming to at least double its previous $10.2 billion valuation. The de-extinction startup has begun generating revenue over the past year, offering its conservation technology to entities like the U.S. government and the UAE, which invested $60 million. Colossal has also spun out three companies, including Form Bio which raised $30 million, and Astromech valued at $2 billion.